Stock Events

Syndax Pharmaceuticals (1T3.F) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.92
-0.88
-0.83
-0.79

Details

Expected EPS
-0.9103162257
Actual EPS
-0.790755
Surprise EPS
0.12
Surprise Percent
+13.13%

Description

Syndax Pharmaceuticals (1T3.F) has reported earnings of -0.790755 per share for Q2 2024.

0 Comments

Share your thoughts